chartexchange

PTGX
Protagonist Therapeutics, Inc
stockNASDAQ

At CloseNov 18, 2026 3:59:51 PM EST
127.22USD+2.045%(+2.55)432,812
After-hoursNov 18, 2026 4:00:30 PM EST
127.16USD-0.047%(-0.06)

PTGX Financials

In Q3 FY 2026 (ended ), Protagonist Therapeutics, Inc (PTGX) reported revenue of $274.41M, net income of $220.02M, operating cash flow of −$23.22M, and assets of $1.15B (filed ).

Loading financial flows…